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SUMMARY
The natural co-infection with dengue virus can occur in highly endemic areas where different serotypes have been observed for 
many years. We report here four cases of DENV-3/DENV-4 co-infection detected by serological and molecular tests among 674 
patients with acute undifferentiated fever from the tropical medicine reference center of Manaus City, Brazil, between 2005 and 2010. 
Analysis of the sequences obtained indicated the presence of genotype 3 and 1 for DENV-3 and DENV-4 respectively.
KEYWORDS: Brazil; Dengue; Co-infection; Flavivirus.
Dengue Fever is the most important arboviral disease worldwide. 
Dengue viruses (DENVs) belong to the genus Flavivirus, family 
Flaviviridae. These are single-stranded positive-sense RNA viruses 
grouped into four antigenically related, but distinct, serotypes named 
DENV-1, 2, 3 and 45. Since the first laboratory-confirmed DENV cases 
at Roraima 1981-1982, more than four million cases of dengue have 
been reported in Brazil11. In Manaus, the capital of the Amazonas State 
in Brazil, all four dengue serotypes have already been reported3,4. Dengue 
virus co-infection cases are poorly documented in literature, although 
our results demonstrate that such cases might be more common than 
expected, mostly in hyperendemic areas.
From January 2005 to December 2010, 674 patients with acute 
undifferentiated fever were treated at a reference center of Tropical 
Medicine (Fundação de Medicina Tropical Doutor Heitor Vieira Dourado 
- FMT-HVD, Manaus, Brazil). These patients were tested for malaria 
by thick blood analyses, and all patients with negative results were 
asked to participate in this study. The participants signed an informed 
consent form that was approved by the FMTAM Ethical Committee 
Board (272/2005). Two blood samples were collected from each patient, 
one in the acute phase of the disease and the other in the convalescent 
form. Sera from the convalescent phase were used for detection of anti-
dengue immunoglobulin M (IgM) specific antibodies by MAC-ELISA, 
as previously described 9.
Acute-phase samples were used in two tests: one for viral isolation 
in C6/36 Aedes albopictus cell line, followed by viral identification 
using an indirect immunofluorescent test with dengue type-specific 
monoclonal antibodies7, kindly provided by Centers for Disease Control 
and Prevention (CDC), Atlanta, Georgia USA; and the other for specific 
DENV nucleic acid amplification. RNA was extracted directly from 
serum samples with the QIAamp Viral RNA Mini-Kit (Qiagen, USA), 
following manufacturer´s instructions and submitted to RT-PCR to be 
followed by semi-nested multiplex PCR as previously described for 
DENV detection and typing10. When samples were positive for any 
serotype of DENV, a second semi-nested PCR, this time in a singleplex 
format, with a type-specific primer (DENV-1 to DENV-4) was performed 
for confirmation. Amplicons from the C/PrM region were purified and 
sequenced in both directions by using the BigDye Terminator Cycle 
Sequence Kit (Applied Biosystems, USA). The genotypes were detected 
by a search tool http://www.denguedb.org/submitGenotypeRequest.
aspx?type=Dengue. 
One hundred and thirty-five samples were positive for DENV: 2 
DENV-1, 25 DENV-2, 71 DENV-3 and 37 for DENV-4. Four individuals, 
three women and one man, ages 40-70 years, had co-infections of DENV-
3 and 4 detected by immunofluorescence assay, RT-PCR and nucleotide 
sequencing (Table 1). Co-infections including distinct dengue serotypes 
are, probably, more common in tropical regions of the world where 
dengue is hyperendemic, with circulation of the four serotypes8. Risk 
factors for dengue infections and co-infections include the virulence of 
the virus and the density of Aedes6. Larval Index Rapid Assay (LIRA) 
varied from 2.6 to 2.8% between 2005 and 2007 (Table 1). In 2008, 
DENV-4 was reported in Brazil after 25 years of absence4. Although 
the paper was published in 2008, the DENV-4 positive samples were, in 
fact, obtained in 2005 and 2006, kept at -80 oC in FMT-HVD fever serum 
collection and analyzed in the second half of the year 2007 (Figueiredo, 
R.M. personal communication), which indicates that DENV-4 might have 
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been circulating in a silent cryptic way in northern Brazil in the last few 
years. In 2010, the LIRA was 1.5%, showing an alarming situation in 
Manaus which led to the dengue fever outbreak in the first three months 
of 2011 (unpublished data).
According to the period of the disease, (Table 1) it was possible to 
observe during convalescence the presence of the DENV by the RT-PCR10 
method, irrespective of the presence or absence of antibodies.
Nucleotide sequence analysis shows genotype 3 for DENV-3, 
although the reliability is not 100% due to the small size analyzed (Table 
1), whereas DENV-4 samples were typed as genotype 1, in accordance 
with previous analyses2. Regarding the circulation of DENV-4 of 
genotype I, causing cases of human infection in Manaus, it is possible that 
DENV-4 of genotype I has been introduced by international visitors or by 
imported mosquitoes from Asia2. The isolates reported here were from 
patients with no travel history, which indicates autochthonous infection.
In Brazil, one case of co-infection by DENV- 1 and DENV-2 was 
reported in a patient with classic dengue fever (DF) from the southeast 
region, in 200112. Another case of co-infection by DENV-2 and DENV-
3 was reported in 2005 in a patient DF from the northeast region, who 
recovered without a relapse1. During an outbreak of dengue in São José 
do Rio Preto, in the state of São Paulo, 365 samples showed positive 
to DENV-3, five samples were positive to DENV-2, and 8 to St. Louis 
encephalitis flavivirus (SLEV). Among the positive samples, one 
co-infection was detected between DENV-2 and DENV-313. Hence, 
co-infection with distinct DENV serotypes during outbreaks may be 
expected.
The co-infected patients presented benign clinical examinations and 
recovered without sequel, corroborating with previous reports12. Here, 
we report cases of co-infection by dengue in the state of Amazonas, 
concurrent with the first reported cases of DENV-4 in Brazil after Roraima 
1981-1982. Viral evolution of DENV-4 cases from Manaus should be 
studied in detail since it is an Asian genotype that has been associated 
with DHF in the Asian continent.
RESUMO
Co-infecção pelo vírus dengue 3 e 4 em pacientes da Amazônia 
brasileira
 A co-infecção natural com os vírus dengue pode ocorre em áreas 
altamente endêmicas onde diferentes sorotipos têm sido transmitidos por 
muitos anos. Relatamos aqui quatro casos de co-infecção com DENV-3/
DENV-4 detectados por testes sorológicos e moleculares entre 674 
pacientes com febre indiferenciada aguda, atendidos em um centro de 
medicina tropical de referência da cidade de Manaus, Brasil, entre 2005 
e 2010. As análises das sequências obtidas indicaram a presença dos 
genotipos 3 e 1 para DENV-3 e DENV-4 respectivamente.
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Table 1 
Results of different methods used for identification of dengue virus serotypes co-infecting 4 patients
Sample Accession numbers









AM707 JF923865DENV-3JF923866 DENV-4 N.I. 02/25/2005
(DENV-3 / GIII*)
(DENV-4 / GI) ND 2.6
AM726 JF923879 DENV-3 JF923880 DENV-4 N.I. 02/28/2005
(DENV-3 / GIII*)
(DENV-4 / GI) ND 2.6





+AM2220 JF923873, DENV-4 11/27/2007 11/28/2007 (DENV-4 / GI) Positive12/05/2007 2.8
N.I. = not informed; ND = Test not done; + The sequence of DENV-3 was of poor quality; * The genotypes presented were of highest probability despite the small size 
of the PCR fragment sequenced; The genotypes were those most likely, although the reliability is not 100% due to the small size analyzed.
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